Question: how long has rytary been on the market?
Answer: Click here to subscribe to the Parkinson's News Today Newsletter! Rytary (formerly known as IPX066) consist of carbidopa and levodopa extended-release capsules for early, moderate, and advanced Parkinson's Disease (PD) treatment. The drug has been approved by the U.S. Food and Drug Administration (FDA) in 2015.